Together, these results demonstrate that M2pep‐Cs NPs/Plerixafor NPs effectively inhibit tumor growth in vivo by modulating the CXCL12–CXCR4 axis and promoting TAM reprogramming. Here, CXCR4 is linked to neoplasm.